Literature DB >> 16395130

Tumor necrosis factor-alpha gene is not associated with obsessive-compulsive disorder.

Gwyneth Zai1, Paul D Arnold, Eliza Burroughs, Margaret A Richter, James L Kennedy.   

Abstract

Dysregulation of the immune system has been suggested to play a role in the complex etiology of obsessive-compulsive disorder. In this context, tumor necrosis factor-alpha is considered an interesting candidate for genetic studies as overproduction of tumor necrosis factor-alpha, which may be genetically modulated, can exert neurotoxic effects and influence neural cell growth and proliferation. Moreover, the tumor necrosis factor-alpha gene is located on chromosome 6p21.3, a region that has been found to be weakly associated with obsessive-compulsive disorder in linkage studies. One functional polymorphism, G-308A, has been found within the gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395130     DOI: 10.1097/01.ypg.0000185026.12687.92

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  4 in total

1.  The Genetics of Obsessive-Compulsive Disorder.

Authors:  Michael H Bloch; Christopher Pittenger
Journal:  Curr Psychiatry Rev       Date:  2010-05-01

Review 2.  Neuroinflammation and psychiatric illness.

Authors:  Souhel Najjar; Daniel M Pearlman; Kenneth Alper; Amanda Najjar; Orrin Devinsky
Journal:  J Neuroinflammation       Date:  2013-04-01       Impact factor: 8.322

3.  Association between pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections disease and tumor necrosis factor-α gene-308 g/a, -850 c/t polymorphisms in 4-12-year-old children in Adana/Turkey.

Authors:  H Umit Luleyap; Dilge Onatoglu; M Bertan Yilmaz; Davut Alptekin; Aysegul Y Tahiroglu; Salih Cetiner; Ayfer Pazarbasi; Ilker Unal; Ayse Avci; Gamze Comertpay
Journal:  Indian J Hum Genet       Date:  2013-04

Review 4.  Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside.

Authors:  Mujeeb U Shad
Journal:  Behav Sci (Basel)       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.